|
|
| SECTION A HUMAN NECESSITIES |
| A 61 | MEDICAL OR VETERINARY SCIENCE; HYGIENE |
| A 61 L | METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agent employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toilet purposes A61K; preparation of ozone C01B 13/10) [4] |
24/ | 00 | Surgical adhesives or cements; Adhesives for colostomy devices [7] |
| Notes |
| (1) | In groups A61L 24/02 to A61L 24/12, in the absence of an indication to the contrary, classification is made in the last appropriate place. [7] |
| (2) | When classifying in group A61L 24/00, classification is also made in A61L 33/00 if the materials used are antithrombogenic. [7] |
24/ | 02 | . | containing inorganic materials [7] |
24/ | 04 | . | containing macromolecular materials [7] |
24/ | 06 | . | . | obtained by reactions only involving carbon-to-carbon unsaturated bonds [7] |
24/ | 08 | . | . | Polysaccharides [7] |
24/ | 10 | . | . | Polypeptides; Proteins [7] |
24/ | 12 | . | . | Ionomer cements, e.g. glass-ionomer cements [7] |
25/ | 00 | (transferred to A61L 24/00, A61L 26/00, A61L 28/00) |
26/ | 00 | Chemical aspects of, or use of materials for, liquid bandages [7] |
| Note |
| When classifying in group A61L 26/00, classification is also made in A61L 33/00 if the materials used are antithrombogenic. [7] |
27/ | 00 | Materials for prostheses or for coating prostheses (dental prostheses A61C 13/00; shape or structure of prostheses A61F 2/00; use of preparations for artificial teeth A61K 6/02; artificial kidneys A61M 1/14) [4] |
| Notes |
| (1) | In groups A61L 27/02 to A61L 27/48, in the absence of an indication to the contrary, classification is made in the last appropriate place. [7] |
| (2) | When classifying in groups A61L 27/02 to A61L 27/48, classification is also made in groups A61L 27/50 to A61L 27/60 if the use of materials characterised by their function or physical properties is of interest. [7] |
| (3) | When classifying in group A61L 27/00, classification is also made in A61L 33/00 if the materials used are antithrombogenic. [7] |
27/ | 02 | . | Inorganic materials [7] |
27/ | 04 | . | . | Metals or alloys [7] |
27/ | 06 | . | . | . | Titanium or titanium alloys [7] |
27/ | 08 | . | . | Carbon [7] |
27/ | 10 | . | . | Ceramics or glasses [7] |
27/ | 12 | . | . | Phosphorus-containing materials, e.g. apatite [7] |
27/ | 14 | . | Macromolecular materials [7] |
27/ | 16 | . | . | obtained by reactions only involving carbon-to-carbon unsaturated bonds [7] |
27/ | 18 | . | . | obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] |
27/ | 20 | . | . | Polysaccharides [7] |
27/ | 22 | . | . | Polypeptides or derivatives thereof [7] |
27/ | 24 | . | . | . | Collagen [7] |
27/ | 26 | . | . | Mixtures of macromolecular materials [7] |
27/ | 28 | . | Materials for coating prostheses [7] |
27/ | 30 | . | . | Inorganic materials [7] |
27/ | 32 | . | . | . | Phosphorus-containing materials, e.g. apatite [7] |
27/ | 34 | . | . | Macromolecular materials [7] |
27/ | 36 | . | containing ingredients of undetermined constitution or reaction products thereof [7] |
27/ | 38 | . | . | Animal cells (for use in artificial skin A61L 27/60) [7] |
27/ | 40 | . | Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material [7] |
27/ | 42 | . | . | having an inorganic matrix [7] |
27/ | 44 | . | . | having a macromolecular matrix [7] |
27/ | 46 | . | . | . | with phosphorus-containing inorganic fillers [7] |
27/ | 48 | . | . | . | with macromolecular fillers [7] |
27/ | 50 | . | Materials characterised by their function or physical properties [7] |
27/ | 52 | . | . | Hydrogels or hydrocolloids [7] |
27/ | 54 | . | . | Biologically active materials, e.g. therapeutic substances [7] |
27/ | 56 | . | . | Porous or cellular materials [7] |
27/ | 58 | . | . | Materials at least partially resorbable by the body [7] |
27/ | 60 | . | . | Materials for use in artificial skin [7] |
28/ | 00 | Materials for colostomy devices (adhesives for colostomy devices A61L 24/00) [7] |
| Note |
| When classifying in group A61L 28/00, classification is also made in A61L 33/00 if the materials used are antithrombogenic. [7] |
29/ | 00 | Materials for catheters or for coating catheters (shape or structure of catheters A61M 25/00) [4] |
| Notes |
| (1) | In groups A61L 29/02 to A61L 29/12, in the absence of an indication to the contrary, classification is made in the last appropriate place. [7] |
| (2) | When classifying in groups A61L 29/02 to A61L 29/12, classification is also made in groups A61L 29/14 to A61L 29/18 if the use of materials characterised by their function or physical properties is of interest. [7] |
| (3) | When classifying in group A61L 29/00, classification is also made in A61L 33/00 if the materials used are antithrombogenic. [7] |
29/ | 02 | . | Inorganic materials [7] |
29/ | 04 | . | Macromolecular materials [7] |
29/ | 06 | . | . | obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] |
29/ | 08 | . | Materials for coatings [7] |
29/ | 10 | . | . | Inorganic materials [7] |
29/ | 12 | . | Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material [7] |
29/ | 14 | . | Materials characterised by their function or physical properties [7] |
29/ | 16 | . | . | Biologically active materials, e.g. therapeutic substances [7] |
29/ | 18 | . | . | Materials at least partially X-ray or laser opaque [7] |
31/ | 00 | Materials for other surgical articles [4] |
| Notes |
| (1) | In groups A61L 31/02 to A61L 31/12, in the absence of an indication to the contrary, classification is made in the last appropriate place. [7] |
| (2) | When classifying in groups A61L 31/02 to A61L 31/12, classification is also made in groups A61L 31/14 to A61L 31/18 if the use of materials characterised by their function or physical properties is of interest. [7] |
| (3) | When classifying in group A61L 31/00, classification is also made in A61L 33/00 if the materials used are antithrombogenic. [7] |
31/ | 02 | . | Inorganic materials [7] |
31/ | 04 | . | Macromolecular materials [7] |
31/ | 06 | . | . | obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds [7] |
31/ | 08 | . | Materials for coatings [7] |
31/ | 10 | . | . | Macromolecular materials [7] |
31/ | 12 | . | Composite materials, i.e. layered or containing one material dispersed in a matrix of the same or different material [7] |
31/ | 14 | . | Materials characterised by their function or physical properties [7] |
31/ | 16 | . | . | Biologically active materials, e.g. therapeutic substances [7] |
31/ | 18 | . | . | Materials at least partially X-ray or laser opaque [7] |
33/ | 00 | Antithrombogenic treatment of surgical articles, e.g. sutures, catheters, prostheses, or of articles for the manipulation or conditioning of blood; Materials for such treatment [4,7] |
| Note |
| In groups A61L 33/02 to A61L 33/18, in the absence of an indication to the contrary, classification is made in the last appropriate place. [7] |
33/ | 02 | . | Use of inorganic materials [7] |
33/ | 04 | . | Use of organic materials, e.g. acetylsalicylic acid [7] |
33/ | 06 | . | Use of macromolecular materials [7] |
33/ | 08 | . | . | Polysaccharides [7] |
33/ | 10 | . | . | . | Heparin, heparinoid or derivatives thereof [7] |
33/ | 12 | . | . | Polypeptides, proteins or derivatives thereof [7] |
33/ | 14 | . | Use of fibrinolytic agents or platelet aggregation inhibitors [7] |
33/ | 16 | . | Use of enzymes, e.g. urokinase, streptokinase [7] |
33/ | 18 | . | Use of ingredients of undertermined constitution or reaction products thereof [7] |
| Indexing scheme associated with groups A61L 2/00 to A61L 12/00, relating to the chemical composition of the materials used in disinfecting, sterilising or deodorising. The indexing codes should be unlinked. [7] |
| Note |
| Attention is drawn to Chapter IV of the Guide which sets forth the rules concerning the application and presentation of the different types of indexing code. [7] |
101: | 00 | Chemical composition of materials used in disinfecting, sterilising or deodorising [7] |
101: | 02 | . | Inorganic materials [7] |
101: | 04 | . | . | Elemental carbon, e.g. active charcoal [7] |
101: | 06 | . | . | containing halogen [7] |
101: | 08 | . | . | . | Elemental halogen [7] |
101: | 10 | . | . | Ozone [7] |
101: | 12 | . | . | containing silicon [7] |
101: | 14 | . | . | containing sulfur [7] |
101: | 16 | . | . | containing phosphorus [7] |
101: | 18 | . | . | Ammonia [7] |
101: | 20 | . | . | Acids [7] |
101: | 22 | . | . | Peroxides [7] |
101: | 24 | . | . | containing aluminium [7] |
101: | 26 | . | . | containing copper [7] |
101: | 28 | . | . | containing iron [7] |
101: | 30 | . | . | containing zinc [7] |
101: | 32 | . | Organic compounds [7] |
101: | 34 | . | . | Hydroxy compounds [7] |
101: | 36 | . | . | Carboxylic acids or derivatives thereof [7] |
101: | 38 | . | . | Ethers [7] |
101: | 40 | . | . | containing sulfur [7] |
101: | 42 | . | . | Organo-metallic compounds or complexes [7] |
101: | 44 | . | . | Heterocyclic compounds [7] |
101: | 46 | . | . | Macromolecular compounds [7] |
101: | 48 | . | . | . | obtained by reactions only involving carbon-to-carbon unsaturated bonds [7] |
101: | 50 | . | . | . | Polysaccharides or derivatives thereof [7] |
101: | 52 | . | Micro-organisms or substances produced by or extracted from micro-organisms [7] |
101: | 54 | . | Enzymes [7] |
101: | 56 | . | Plant extracts or vegetable products of undetermined chemical constitution, e.g. plant fibre [7] |
| |